Skip to main content
. 2022 Jan 24;20(1):e07031. doi: 10.2903/j.efsa.2022.7031

Figure 4.

Figure 4

Summary of the RoB conducted for the human lines of evidence. The results were reported per assessment endpoint categories (i.e. neurotoxicity) and per specific assessment endpoint. Red: class 3 risk of bias